Linklaters advises on acquisition of Syngenta AG by ChemChina
- ChemChina's US$43bn acquisition of Syngenta is the largest overseas takeover by a Chinese company in history
- Linklaters advised lenders on the US$20bn bridge facilities for the acquisition
Linklaters advised HSBC Bank plc on the US$20bn loan facilities for the acquisition of Syngenta AG, the Swiss seed and pesticide maker, by China National Chemical Corporation (ChemChina), the Chinese state-owned chemical company.
The Chinese group’s buyout of the seed maker is set to turn the company into an agrichemical powerhouse. Following the receipt of a number of regulatory approvals, final settlement of the tender offers took place on 7 June 2017, with ChemChina acquiring a 94.7 per cent stake in Syngenta making the deal China’s largest ever cross-border acquisition.
The financing of the acquisition consisted of US$15bn term bridge facilities as well as US$5bn backstop facilities made available for the purposes of refinancing existing debt in Syngenta.
The Linklaters team was led by Brian Gray (Banking Partner) and Ian Callaghan (Banking Partner).